October's primary birthstone is the opal. This gem is renowned for its unique play of color and has captivated gem lovers for ...

An announcement from Tourmaline Oil ( ($TSE:TOU) ) is now available. Tourmaline Oil Corp. announced a $200 million secondary offering of Topaz ...

Leaves are changing, everything is pumpkin spice flavored, and Halloween candy is on sale–all of that combined can only mean one thing: It’s October! And what better way to honor our favorite October ...

CNW/ - Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Selling Shareholder") and Topaz Energy Corp. (TSX: TPZ) ("Topaz" ...

Tourmaline Oil is a top-performing natural gas producer, with high asset quality, high-margin profitability, and strong potential for organic production growth. Despite the recent dip in stock prices, ...

Tourmaline Oil stock has seen a slight dip in the consensus analyst price target, moving from CA$74.89 to CA$74.42 as perspectives on the company's outlook evolve. This modest adjustment reflects a ...

With free cash flow guidance of $2.6B, Tourmaline intends to return 50-90% of free cash flow to shareholders in 2023. Investors can anticipate a steadily growing base dividend and special dividends ...

Novartis said Tuesday it is buying Tourmaline Bio for $1.4 billion in a deal that gives the Swiss pharma giant access to the biotech’s late-stage cardiovascular drug pacibekitug.

The market expects Tourmaline Oil Corp. (TRMLF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus ...

Basel, September 29, 2025 - Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer ...

Tourmaline Bio, Inc. has announced the appointment of Dr. Paul M. Ridker to its Cardiovascular Scientific Advisory Board. Dr. Ridker, a prominent figure in cardiovascular research from Harvard Medical ...